MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    A Systematic Review on the Reliability of Data-Driven Parkinson’s Disease Subtypes

    D. Teixeira-Dos-Santos, R. Ravazio, C. Mattjie, A. De-Oliveira-Franco, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, MA. de Bastiani, MA. Machado Schlindwein, L. Angi Souza, T. Hugentobler Schlickmann, S. Duarte Pinto, A. Bieger, R. C. Barros, E. R. Zimmer, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To systematically evaluate data-driven Parkinson’s disease (PD) subtyping studies, focusing on their methodological quality and clinical applicability. Background: The heterogeneity of PD suggests distinct…
  • 2025 International Congress

    Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease

    T. Lata (Mumbai, India)

    Objective: This study aimed to assess the effectiveness of physical activity, which includes all movements that increase energy expenditure, in conjunction with exercise, characterized as…
  • 2025 International Congress

    Noise assessment acoustic measures of sustained vowel in patients with Parkinson’s disease

    I. Khasanov, D. Khasanova (Kazan, Russian Federation)

    Objective: To investigate and quantify the presence of noise in the vocal signals of Parkinson's disease (PD) patients and healthy volunteers (HV) using acoustic measures,…
  • 2025 International Congress

    Long-Term Benefits of Weekly Group Physiotherapy in Slowing Parkinson’s Progression:A 12-Month Non-Randomized Controlled Trial

    E. Tardelli, M. Piemonte, B. Rosa, P. Igarashi, C. Dias (São Paulo, Brazil)

    Objective: To investigate the effects of weekly group PT programs to reduce the progression of motor symptoms severity in PwPD Background: The short-term benefits of…
  • 2025 International Congress

    Caregiver Burden after DBS at GPI or STN for Parkinson’s Disease

    A. Kamath, H. Branstetter, J. Summers, T. Hassell, S. Bick, N. Banerjee, K. Dhima (Nashville, USA)

    Objective: Examine the effects of GPi or STN DBS on caregiver burden for Parkinson's Disease Background: Deep Brain Stimulation (DBS) is a common treatment used…
  • 2025 International Congress

    Long term real-world monitoring supports the superiority of adaptive deep brain stimulation: preliminary data on three patients with Parkinson’s disease

    L. Caffi, R. Habib, L. Borellini, E. Mailland, F. Cogiamanian, M. Arlotti, L. Rossi, S. Bonvegna, C. Palmisano, S. Marceglia, A. Priori, G. Pezzoli, M. Locatelli, IU. Isaias (Würzburg, Germany)

    Objective: Describe the preliminary results of adaptive deep brain stimulation (aDBS) treatment for Parkinson’s disease (PD) and the value of real-world monitoring in defining clinical…
  • 2025 International Congress

    Trends on recruitment and retention in Parkinson’s Disease modification trials

    D. Hengartner, R. Palacio, J. Garinger, A. Lysandropoulos (Durham, USA)

    Objective: To identify the most common causes of participant’s screen failure (SF) and drop-out (DO) in Phase 2 and 3 Disease Modification Therapy (DMT) trials…
  • 2025 International Congress

    A randomised controlled feasibility study of a technology-assisted home-based aerobic exercise program for individuals with Parkinson’s disease

    S. Neo, Z. Yee, W. Li, HL. Ng, R. Hoe, C. Chung (Singapore, Singapore)

    Objective: The study evaluates the effectiveness of Combat PD, a mobile app designed to remotely deliver and monitor gamified aerobic exercise in promoting adherence and…
  • 2025 International Congress

    First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ARV-102, a PROTAC LRRK2 Degrader, in Healthy Participants

    L. Smits, Y. Zhang, C. Woodward, S. Aksenov, A. Costa Zaninotto, C. Donnelly, T. Storz, Y. Folami, P. Patel, C. Lubeski, M. Macdougall, K. Kelly, A. Hendricson, S. Korsten, P. Kremer, A. Cacace, I. Conti (Leiden, Netherlands)

    Objective: To evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ascending doses (SAD/MAD) of ARV-102, a PROteolysis TArgeting Chimera (PROTAC) leucine-rich…
  • 2025 International Congress

    Barriers and Facilitators of Adherence to Mediterranean-Ketogenic and MCT-Supplemented Mediterranean Diets in Parkinson’s Disease: A Qualitative Secondary Analysis from a Random-Order Crossover Trial

    K. Tosefsky, Y. Wang, J. Lam, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To assess the barriers and facilitators of dietary adherence among people with Parkinson’s disease (PD) following an 8-week Mediterranean-ketogenic and 8-week MCT-supplemented Mediterranean diet.…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley